New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Scribe Therapeutics Inc.

SCTX

Healthcare Biotechnology

Scribe Therapeutics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $51.2 million.

12.07 1.15 −8.70%

After hours trading: 12.00, down 0.58%, last trade Fri 7:39pm Eastern.

Market cap
$250.4M
P/E
n/m
Fwd P/E FY26e
n/m
Dividend yield
—
F-score
n/a
ROIC
—
Net debt / EBITDA
—
Payout ratio
—
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
0.00 0.00 0.00 —

+2 more quarters

P/S ratio
10.31 1.84 1.84 —
P/FCF ratio
0.00 0.00 0.00 —
P/Operating CF
(23.72) (4.75) (4.75) —
P/B ratio
2.13 0.00 0.00 —
Price to Tangible BV
2.13 0.00 0.00 —
EV/Sales
3.58 0.36 0.36 —
EV/EBITDA
0.00 0.00 0.00 —
EV/Operating CF
0.00 0.00 0.00 —
EV/FCF
0.00 0.00 0.00 —
Quick Ratio
4.62 0.56 — 0.94
Current Ratio
4.72 0.57 — 0.97
Net Debt/EBITDA
17.26 4.58 — —
Debt/Assets
0.00% 0.00% — 0.00%
Debt/Equity
0.00 0.00 — 0.00
Operating CF/Net income
1.14 — — —
Capex/Depreciation
(0.02) — — —
Interest Coverage
— (34.04) — —
Research and Development Expense of Revenue
504.83% 460.01% — —
Selling, General and Administrative Expense of Revenue
259.11% 129.82% — —
Intangible Assets out of Total Assets
0.00 0.00 — 0.00
Share Based Compensation of Revenue
74.27% — — —
Graham Net Nets
0.44 (1.07) (1.07) —
Graham Number
0.00 140.31 0.00 —
Earnings Yield
(52.93%) (60.70%) (60.70%) —
Free Cash Flow Yield
0.00% 0.00% 0.00% —
Revenue per Share
0.11 0.77 0.91 —
Operating CF per Share
(0.78) — — —
Capex per Share
0.00 — — —
Free Cash Flow per Share
(0.78) — — —
Cash per Share
12.02 17.37 — —
Shareholders Equity per Share
8.63 (17.97) — —
Interest Debt per Share
0.00 0.00 — —
Book value per Share
8.63 (17.97) — —
Free Cash Flow
(11.26) — — —
Working Capital
140.96 (33.59) — (2.12)
Capital Expenditures
(0.01) — — —
Net Current Asset Value
116.13 (57.31) — (34.35)
EV/EBIT
0.00 0.00 0.00 —
Capex to Sales
0.01 — — —
Price to Operating Income
0.00 0.00 0.00 —

Fold the line items

Columns are period end dates · fundamentals updated Nov 18, 2026